Clinical Research Directory
Browse clinical research sites, groups, and studies.
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
Sponsor: National Cancer Institute, Naples
Summary
This is an observational, prospective study enrolling patients who meet the inclusion criteria and provide consent for the use of biopsy samples collected as part of standard clinical practice. The analysis will focus on the following biomarkers: TP53, P16, Cyclin D1, EGFR, Akt, PDL-1, and ERCC1. These biomarkers will be examined in both observation groups.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
128
Start Date
2024-05-03
Completion Date
2032-05
Last Updated
2025-04-01
Healthy Volunteers
No
Interventions
Biomarkers evaluation
Evaluate the prognostic role of the markers TP53, P16, Cyclin D1, EGFR, Akt, PDL-1, ERCC1 examined on biopsy samples.
Locations (1)
Istituto Nazionale Tumori | "Fondazione Pascale"
Naples, Italy